Original Research

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

Restelli U, Croce D, Pacelli V, Ciceri F, Girmenia C

Infection and Drug Resistance 2019, 12:1127-1138

Published Date: 8 May 2019